BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng ZZ, Hellwage J, Seeberger H, Zipfel PF, Meri S, Jokiranta TS. Comparison of surface recognition and C3b binding properties of mouse and human complement factor H. Mol Immunol 2006;43:972-9. [PMID: 16023208 DOI: 10.1016/j.molimm.2005.05.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Lehtinen MJ, Rops AL, Isenman DE, van der Vlag J, Jokiranta TS. Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome. J Biol Chem 2009;284:15650-8. [PMID: 19351878 DOI: 10.1074/jbc.M900814200] [Cited by in Crossref: 74] [Cited by in F6Publishing: 42] [Article Influence: 5.7] [Reference Citation Analysis]
2 Antonioli AH, White J, Crawford F, Renner B, Marchbank KJ, Hannan JP, Thurman JM, Marrack P, Holers VM. Modulation of the Alternative Pathway of Complement by Murine Factor H-Related Proteins. J Immunol 2018;200:316-26. [PMID: 29187587 DOI: 10.4049/jimmunol.1602017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
3 Ajona D, Hsu Y, Corrales L, Montuenga LM, Pio R. Down-Regulation of Human Complement Factor H Sensitizes Non-Small Cell Lung Cancer Cells to Complement Attack and Reduces In Vivo Tumor Growth. J Immunol 2007;178:5991-8. [DOI: 10.4049/jimmunol.178.9.5991] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 4.4] [Reference Citation Analysis]
4 Huber G, Bánki Z, Kunert R, Stoiber H. Novel bifunctional single-chain variable antibody fragments to enhance virolysis by complement: generation and proof-of-concept. Biomed Res Int 2014;2014:971345. [PMID: 24524088 DOI: 10.1155/2014/971345] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Banda NK, Mehta G, Ferreira VP, Cortes C, Pickering MC, Pangburn MK, Arend WP, Holers VM. Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis. J Immunol 2013;190:3560-9. [PMID: 23436934 DOI: 10.4049/jimmunol.1203271] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
6 Koskinen AR, Cheng ZZ, Pickering MC, Kairemo K, Meri T, Cook HT, Meri S, Jokiranta TS. Distribution of exogenous complement factor H in mice in vivo. Scand J Immunol 2018;88:e12671. [PMID: 29706017 DOI: 10.1111/sji.12671] [Reference Citation Analysis]
7 Ricklin D, Lambris JD. Exploring the complement interaction network using surface plasmon resonance. Adv Exp Med Biol 2007;598:260-78. [PMID: 17892218 DOI: 10.1007/978-0-387-71767-8_19] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
8 Pickering MC, de Jorge EG, Martinez-Barricarte R, Recalde S, Garcia-Layana A, Rose KL, Moss J, Walport MJ, Cook HT, de Córdoba SR. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J Exp Med. 2007;204:1249-1256. [PMID: 17517971 DOI: 10.1084/jem.20070301] [Cited by in Crossref: 201] [Cited by in F6Publishing: 180] [Article Influence: 13.4] [Reference Citation Analysis]
9 de Taeye SW, Kreuk L, van Dam AP, Hovius JW, Schuijt TJ. Complement evasion by Borrelia burgdorferi: it takes three to tango. Trends Parasitol 2013;29:119-28. [PMID: 23298533 DOI: 10.1016/j.pt.2012.12.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
10 Gilmore AC, Zhang Y, Cook HT, Lavin DP, Katti S, Wang Y, Johnson KK, Kim S, Pickering MC. Complement activity is regulated in C3 glomerulopathy by IgG-factor H fusion proteins with and without properdin targeting domains. Kidney Int 2021;99:396-404. [PMID: 33129896 DOI: 10.1016/j.kint.2020.09.028] [Reference Citation Analysis]
11 Sethi S, Gamez JD, Vrana JA, Theis JD, Bergen HR 3rd, Zipfel PF, Dogan A, Smith RJ. Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway. Kidney Int. 2009;75:952-960. [PMID: 19177158 DOI: 10.1038/ki.2008.657] [Cited by in Crossref: 136] [Cited by in F6Publishing: 114] [Article Influence: 10.5] [Reference Citation Analysis]
12 Cserhalmi M, Csincsi ÁI, Mezei Z, Kopp A, Hebecker M, Uzonyi B, Józsi M. The Murine Factor H-Related Protein FHR-B Promotes Complement Activation. Front Immunol 2017;8:1145. [PMID: 28974948 DOI: 10.3389/fimmu.2017.01145] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
13 Fraczek LA, Martin BK. Transcriptional control of genes for soluble complement cascade regulatory proteins. Mol Immunol 2010;48:9-13. [PMID: 20869772 DOI: 10.1016/j.molimm.2010.08.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
14 Rich RL, Myszka DG. Survey of the year 2006 commercial optical biosensor literature. J Mol Recognit 2007;20:300-66. [DOI: 10.1002/jmr.862] [Cited by in Crossref: 94] [Cited by in F6Publishing: 77] [Article Influence: 6.3] [Reference Citation Analysis]
15 Nichols EM, Barbour TD, Pappworth IY, Wong EK, Palmer JM, Sheerin NS, Pickering MC, Marchbank KJ. An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy. Kidney Int 2015;88:1314-22. [PMID: 26221753 DOI: 10.1038/ki.2015.233] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
16 Roumenina LT, Rayes J, Frimat M, Fremeaux-Bacchi V. Endothelial cells: source, barrier, and target of defensive mediators. Immunol Rev 2016;274:307-29. [PMID: 27782324 DOI: 10.1111/imr.12479] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 10.8] [Reference Citation Analysis]
17 Ramu P, Tanskanen R, Holmberg M, Lähteenmäki K, Korhonen TK, Meri S. The surface protease PgtE of Salmonella enterica affects complement activity by proteolytically cleaving C3b, C4b and C5. FEBS Lett 2007;581:1716-20. [PMID: 17418141 DOI: 10.1016/j.febslet.2007.03.049] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
18 Brissette CA, Cooley AE, Burns LH, Riley SP, Verma A, Woodman ME, Bykowski T, Stevenson B. Lyme borreliosis spirochete Erp proteins, their known host ligands, and potential roles in mammalian infection. Int J Med Microbiol 2008;298 Suppl 1:257-67. [PMID: 18248770 DOI: 10.1016/j.ijmm.2007.09.004] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
19 Jokiranta TS, Jaakola VP, Lehtinen MJ, Pärepalo M, Meri S, Goldman A. Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome. EMBO J 2006;25:1784-94. [PMID: 16601698 DOI: 10.1038/sj.emboj.7601052] [Cited by in Crossref: 126] [Cited by in F6Publishing: 118] [Article Influence: 7.9] [Reference Citation Analysis]
20 Pickering MC, Cook HT. Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. Clin Exp Immunol 2008;151:210-30. [PMID: 18190458 DOI: 10.1111/j.1365-2249.2007.03574.x] [Cited by in Crossref: 130] [Cited by in F6Publishing: 111] [Article Influence: 9.3] [Reference Citation Analysis]
21 Barata L, Miwa T, Sato S, Kim D, Mohammed I, Song WC. Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack. J Immunol. 2013;190:2886-2895. [PMID: 23390291 DOI: 10.4049/jimmunol.1202536] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
22 Hellwage J, Eberle F, Babuke T, Seeberger H, Richter H, Kunert A, Härtl A, Zipfel PF, Jokiranta TS, Józsi M. Two factor H-related proteins from the mouse: expression analysis and functional characterization. Immunogenetics 2006;58:883-93. [DOI: 10.1007/s00251-006-0153-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
23 Lu L, Ma Z, Jokiranta TS, Whitney AR, DeLeo FR, Zhang JR. Species-specific interaction of Streptococcus pneumoniae with human complement factor H. J Immunol 2008;181:7138-46. [PMID: 18981135 DOI: 10.4049/jimmunol.181.10.7138] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
24 Huang Y, Qiao F, Atkinson C, Holers VM, Tomlinson S. A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury. J Immunol 2008;181:8068-76. [PMID: 19017999 DOI: 10.4049/jimmunol.181.11.8068] [Cited by in Crossref: 92] [Cited by in F6Publishing: 95] [Article Influence: 6.6] [Reference Citation Analysis]
25 Pouw RB, Vredevoogd DW, Kuijpers TW, Wouters D. Of mice and men: The factor H protein family and complement regulation. Mol Immunol 2015;67:12-20. [PMID: 25824240 DOI: 10.1016/j.molimm.2015.03.011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
26 Agarwal V, Asmat TM, Luo S, Jensch I, Zipfel PF, Hammerschmidt S. Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells. J Biol Chem 2010;285:23486-95. [PMID: 20504767 DOI: 10.1074/jbc.M110.142703] [Cited by in Crossref: 63] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]